Shioda T - Search Results

1

Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells.

Shimizu J, Sasaki T, Koketsu R, Morita R, Yoshimura Y, Murakami A, Saito Y, Kusunoki T, Samune Y, Nakayama EE, Miyazaki K, Shioda T. Shimizu J, et al. Among authors: shioda t. Sci Rep. 2022 Sep 16;12(1):15612. doi: 10.1038/s41598-022-19993-w. Sci Rep. 2022. PMID: 36114224 Free PMC article.

2

Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion.

Nakayama EE, Shioda T, Tatsumi M, Xin X, Yu D, Ohgimoto S, Kato A, Sakai Y, Ohnishi Y, Nagai Y. Nakayama EE, et al. Among authors: shioda t. FEBS Lett. 1998 Apr 24;426(3):367-72. doi: 10.1016/s0014-5793(98)00375-5. FEBS Lett. 1998. PMID: 9600268 Free article.

3

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

Shioda T, Kato H, Ohnishi Y, Tashiro K, Ikegawa M, Nakayama EE, Hu H, Kato A, Sakai Y, Liu H, Honjo T, Nomoto A, Iwamoto A, Morimoto C, Nagai Y. Shioda T, et al. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6331-6. doi: 10.1073/pnas.95.11.6331. Proc Natl Acad Sci U S A. 1998. PMID: 9600965 Free PMC article.

4

Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity.

Ohgimoto S, Shioda T, Mori K, Nakayama EE, Hu H, Nagai Y. Ohgimoto S, et al. Among authors: shioda t. J Virol. 1998 Oct;72(10):8365-70. doi: 10.1128/JVI.72.10.8365-8370.1998. J Virol. 1998. PMID: 9733886 Free PMC article.

5

[Host genetic polymorphisms affect HIV-1 diseases].

Shioda T, Nakayama EE. Shioda T, et al. Uirusu. 2000 Jun;50(1):65-72. Uirusu. 2000. PMID: 10998980 Free article. Review. Japanese. No abstract available.

6

A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene.

Nakayama EE, Wasi C, Ajisawa A, Iwamoto A, Shioda T. Nakayama EE, et al. Among authors: shioda t. Genes Immun. 2000;1(4):293-4. doi: 10.1038/sj.gene.6363672. Genes Immun. 2000. PMID: 11196708

7

Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.

Shioda T, Nakayama EE, Tanaka Y, Xin X, Liu H, Kawana-Tachikawa A, Kato A, Sakai Y, Nagai Y, Iwamoto A. Shioda T, et al. J Virol. 2001 Apr;75(7):3462-8. doi: 10.1128/JVI.75.7.3462-3468.2001. J Virol. 2001. PMID: 11238872 Free PMC article.

8

Novel polymorphisms in human macrophage inflammatory protein-1 alpha (MIP-1alpha) gene.

Xin X, Nakamura K, Liu H, Nakayama EE, Goto M, Nagai Y, Kitamura Y, Shioda T, Iwamoto A. Xin X, et al. Among authors: shioda t. Genes Immun. 2001 May;2(3):156-8. doi: 10.1038/sj.gene.6363759. Genes Immun. 2001. PMID: 11426325

9

Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load.

Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, Delfraissy JF, Debre P, McIlroy D, Theodorou I, Shioda T; SEROCO Study Group. Nakayama EE, et al. Among authors: shioda t. J Infect Dis. 2002 Apr 15;185(8):1183-6. doi: 10.1086/339825. Epub 2002 Mar 20. J Infect Dis. 2002. PMID: 11930331

10

[Host genetic polymorphisms in the pathogenesis of HIV-1 disease].

Nakayama EE, Shioda T. Nakayama EE, et al. Among authors: shioda t. Nihon Rinsho. 2002 Apr;60(4):724-31. Nihon Rinsho. 2002. PMID: 11968779 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters